Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Senbiao Fang, Chuqi Lei, Yongfan Ming, Liren Liu, Xuming Zhou
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/s2213-2600(20)30076-x
10.1016/s2213-2600(20)30076-x
10.1056/nejmoa2102214
10.1056/nejmoa2102214
10.1016/s0140-6736(20)32466-1
10.1016/s0140-6736(20)32466-1
10.1001/jama.2020.15543
10.1001/jama.2020.15543
10.1016/s1473-3099(20)30843-4
10.1016/s1473-3099(20)30843-4
COVID antiviral pills: what scientists still want to know
10.1038/d41586-021-03074-5 · 2021
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
10.1038/d41586-021-02783-1 · 2021
10.1126/science.abe8499
10.1126/science.abe8499
10.1016/j.cell.2021.02.033
10.1016/j.cell.2021.02.033
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
10.1038/s42003-021-02728-4 · 2021
SARS-CoV-2 variants are selecting for Spike protein mutations that increase protein stability
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1021/acs.jcim.1c00990 · 2021
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
10.1038/s41392-021-00695-0 · 2021
New variant of SARS-CoV-2 in UK causes surge of COVID-19.
10.1016/s2213-2600(21)00005-9 · 2021
10.1126/science.abf9302
10.1126/science.abf9302
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5
10.1038/s41579-021-00573-0
10.1038/s41579-021-00573-0
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
10.1126/science.abc5881 · 2020
An online coronavirus analysis platform from the National Genomics Data Center
10.24272/j.issn.2095-8137.2020.065 · 2020
Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species
10.1093/bib/bbaa329 · 2020
In silico prediction of new mutations that can improve the binding abilities between 2019-nCoV coronavirus and human ACE2
10.1109/tcbb.2021.3058265 · 2021
10.1002/jcc.20084
10.1002/jcc.20084
10.1002/prot.24551
10.1002/prot.24551
10.1021/ct200909j
10.1021/ct200909j
10.1038/s41586-020-2008-3
10.1038/s41586-020-2008-3
10.1080/22221751.2020.1743767
10.1080/22221751.2020.1743767
A simple method of estimating fifty-percent endpoints
10.1093/oxfordjournals.aje.a118408 · 1938
No additional external references are available.